Zavain Dar - Jul 8, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Jul 8, 2022
Transactions value $
$0
Form type
4
Date filed
7/12/2022, 05:01 PM
Previous filing
Jun 16, 2022
Next filing
Apr 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Other $0 +2.42K +13.34% $0.00 20.6K Jul 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro data distribution from Lux Ventures IV, L.P. and its affiliates, in a transaction which is exempt pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.